Parkinson disease: Insights in clinical, genetic and pathological features of monogenic disease subtypes

[1]  J. Kulisevsky,et al.  Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes. , 2011, Archives of neurology.

[2]  C. van Broeckhoven,et al.  Juvenile dystonia-parkinsonism and dementia caused by a novel ATP13A2 frameshift mutation. , 2011, Parkinsonism & related disorders.

[3]  J. Nutt,et al.  Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[4]  T. Hashimoto,et al.  Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism , 2010, Neurology.

[5]  S. Pappatà,et al.  Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability , 2010, neurogenetics.

[6]  K. Marder,et al.  Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. , 2010, Archives of neurology.

[7]  S. Bardien,et al.  Analysis of exon dosage using MLPA in South African Parkinson's disease patients , 2010, neurogenetics.

[8]  J. Hardy,et al.  ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation , 2010, Movement disorders : official journal of the Movement Disorder Society.

[9]  C. Broeckhoven,et al.  GIGYF2 in Parkinson's disease: Innocent until proven otherwise , 2010, Neurobiology of Aging.

[10]  F. Binkofski,et al.  Nonmotor symptoms in genetic Parkinson disease. , 2010, Archives of neurology.

[11]  Marc Cruts,et al.  Genetic Etiology of Parkinson Disease Associated with Mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 Genes: A Mutation Update , 2010, Human mutation.

[12]  R. Krüger,et al.  First appraisal of brain pathology owing to A30P mutant alpha‐synuclein , 2010, Annals of neurology.

[13]  M. Farrer,et al.  LRRK2 and Parkinson disease. , 2010, Archives of neurology.

[14]  P. Pástor,et al.  PINK1-linked parkinsonism is associated with Lewy body pathology. , 2010, Brain : a journal of neurology.

[15]  A. Antonini,et al.  alpha-Synuclein multiplication analysis in Italian familial Parkinson disease. , 2010, Parkinsonism & related disorders.

[16]  J. Hindle,et al.  Ageing, neurodegeneration and Parkinson's disease. , 2010, Age and ageing.

[17]  Thomas Gasser,et al.  Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria , 2009, The Lancet Neurology.

[18]  Yusuke Nakamura,et al.  Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease , 2009, Nature Genetics.

[19]  M. Farrer,et al.  A Swedish family with de novo alpha-synuclein A53T mutation: evidence for early cortical dysfunction. , 2009, Parkinsonism & related disorders.

[20]  Thomas Foltynie,et al.  The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. , 2009, Brain : a journal of neurology.

[21]  F. Binkofski,et al.  ATP13A2 variants in early‐onset Parkinson's disease patients and controls , 2009, Movement disorders : official journal of the Movement Disorder Society.

[22]  Sonja W. Scholz,et al.  Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease , 2009, Nature Genetics.

[23]  M. Nalls,et al.  Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. , 2009, The New England journal of medicine.

[24]  I. Ferrer,et al.  Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2 , 2009, Movement disorders : official journal of the Movement Disorder Society.

[25]  M. Farrer,et al.  Expanding the clinical phenotype of SNCA duplication carriers , 2009, Movement disorders : official journal of the Movement Disorder Society.

[26]  C. van Broeckhoven,et al.  Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population , 2009, Human mutation.

[27]  A. Singleton,et al.  Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. , 2009, Brain : a journal of neurology.

[28]  P. Silburn,et al.  Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia. , 2009, Parkinsonism & related disorders.

[29]  P. Heutink,et al.  Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[30]  W. Oyen,et al.  FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome , 2009, Neurology.

[31]  Y. Agid,et al.  A multidisciplinary study of patients with early-onset PD with and without parkin mutations , 2009, Neurology.

[32]  Y. Sohn,et al.  Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease , 2008, Neurogenetics.

[33]  A. Elbaz,et al.  Update in the epidemiology of Parkinson's disease , 2008, Current opinion in neurology.

[34]  E. Tolosa,et al.  Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study , 2008, The Lancet Neurology.

[35]  P. Matthews,et al.  LRRK2 Gly2019Ser penetrance in Arab–Berber patients from Tunisia: a case-control genetic study , 2008, The Lancet Neurology.

[36]  D. Hernandez,et al.  Characterization of PLA2G6 as a locus for dystonia‐parkinsonism , 2008, Annals of neurology.

[37]  M. Farrer,et al.  LRRK2 mutation in familial Parkinson's disease in a Taiwanese population: clinical, PET, and functional studies. , 2008, Journal of biomedical science.

[38]  C. Mariani,et al.  Parkin analysis in early onset Parkinson's disease. , 2008, Parkinsonism & related disorders.

[39]  G. Halliday,et al.  The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years , 2008, Movement disorders : official journal of the Movement Disorder Society.

[40]  N. Hattori,et al.  PARK9-LINKED PARKINSONISM IN EASTERN ASIA: MUTATION DETECTION IN ATP13A2 AND CLINICAL PHENOTYPE , 2008, Neurology.

[41]  C. Lautier,et al.  Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease. , 2008, American journal of human genetics.

[42]  D. Dickson,et al.  Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson’s disease , 2008, Acta Neuropathologica.

[43]  A. Kakita,et al.  Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia. , 2008, Archives of neurology.

[44]  M. T. Pellecchia,et al.  PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum , 2008, Human mutation.

[45]  N. Hattori,et al.  CLINICOPATHOLOGIC STUDY OF A SNCA GENE DUPLICATION PATIENT WITH PARKINSON DISEASE AND DEMENTIA , 2008, Neurology.

[46]  B. Jeon,et al.  α-Synuclein gene duplication is present in sporadic Parkinson disease , 2008, Neurology.

[47]  E. Tolosa,et al.  Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force , 2007, Movement disorders : official journal of the Movement Disorder Society.

[48]  M. Farrer,et al.  Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain. , 2007, Parkinsonism & related disorders.

[49]  Nir Giladi,et al.  The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease , 2007, Neurology.

[50]  T. Yen,et al.  PINK1 mutation in Taiwanese early-onset parkinsonism , 2007, Journal of Neurology.

[51]  E. Tolosa,et al.  Clinical diagnostic criteria for dementia associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[52]  R. Marconi,et al.  ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease , 2007, Neurology.

[53]  C. Ki,et al.  The Ala53Thr mutation in the α‐synuclein gene in a Korean family with Parkinson disease , 2007 .

[54]  M. Farrer,et al.  Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions , 2007, Acta Neuropathologica.

[55]  M. Farrer,et al.  Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication , 2007, Neurology.

[56]  N. Hattori,et al.  Neuropsychiatric and cognitive features in autosomal‐recessive early parkinsonism due to PINK1 mutations , 2007, Movement disorders : official journal of the Movement Disorder Society.

[57]  A. Destée,et al.  LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans. , 2007, Archives of neurology.

[58]  E. Tolosa,et al.  G2019S LRRK2 mutation causing Parkinson’s disease without Lewy bodies , 2007, Journal of Neurology, Neurosurgery & Psychiatry.

[59]  F. Brancati,et al.  Whole gene deletion and splicing mutations expand the PINK1 genotypic spectrum , 2007, Human mutation.

[60]  G. Schellenberg,et al.  Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients , 2007, Annals of neurology.

[61]  T. Foroud,et al.  Mutations in LRRK2 other than G2019S are rare in a north american–based sample of familial Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[62]  A. Singleton,et al.  Parkinson's disease due to the R1441G mutation in Dardarin: A founder effect in the basques , 2006, Movement disorders : official journal of the Movement Disorder Society.

[63]  J. Cappell,et al.  Tiagabine-induced nonconvulsive status epilepticus in an adolescent without epilepsy , 2006, Neurology.

[64]  M. Farrer,et al.  Parkinsonism, Lrrk2 G2019S, and tau neuropathology , 2006, Neurology.

[65]  O. Sydow,et al.  Leucine‐rich repeat kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy nonagenarian , 2006, Movement disorders : official journal of the Movement Disorder Society.

[66]  N. Quinn,et al.  A heterozygous effect for PINK1 mutations in Parkinson's disease? , 2006, Annals of neurology.

[67]  Jan Gründemann,et al.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase , 2006, Nature Genetics.

[68]  P. Pramstaller,et al.  Heterozygous PINK1 mutations: A susceptibility factor for Parkinson disease? , 2006, Movement disorders : official journal of the Movement Disorder Society.

[69]  A. Varrone,et al.  PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism , 2006, Movement disorders : official journal of the Movement Disorder Society.

[70]  C. Ki,et al.  Clinical features and gene analysis in Korean patients with early-onset Parkinson disease. , 2006, Archives of neurology.

[71]  D. D. De Silva,et al.  PINK1 mutations in sporadic early‐onset Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[72]  M. Breteler,et al.  Epidemiology of Parkinson's disease , 2006, The Lancet Neurology.

[73]  T. Gillis,et al.  Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. , 2006, Archives of neurology.

[74]  J. Nutt,et al.  Parkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinics , 2006, Movement disorders : official journal of the Movement Disorder Society.

[75]  Stéphane Thobois,et al.  Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa. , 2006, Brain : a journal of neurology.

[76]  E. Tolosa,et al.  LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance. , 2006, Archives of neurology.

[77]  K. Chaudhuri,et al.  Non-motor symptoms of Parkinson's disease: diagnosis and management , 2006, The Lancet Neurology.

[78]  R. Marconi,et al.  Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease , 2006, European Journal of Human Genetics.

[79]  A. Singleton,et al.  Analysis of the PINK1 gene in a cohort of patients with sporadic early-onset parkinsonism in Taiwan , 2006, Neuroscience Letters.

[80]  Irene Litvan,et al.  Lrrk2 and Lewy body disease , 2006, Annals of neurology.

[81]  J. Trojanowski,et al.  Biochemical and pathological characterization of Lrrk2 , 2006, Annals of neurology.

[82]  J. Jankovic,et al.  Heterogeneous phenotype in a family with compound heterozygous parkin gene mutations. , 2006, Archives of neurology.

[83]  A. Singleton,et al.  Clinical heterogeneity of α‐synuclein gene duplication in Parkinson's disease , 2006 .

[84]  Christine Klein,et al.  LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. , 2006, The New England journal of medicine.

[85]  P. Pollak,et al.  LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. , 2006, The New England journal of medicine.

[86]  A. Singleton,et al.  Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data. , 2005, Brain : a journal of neurology.

[87]  P. Ragonese,et al.  DJ‐1 mutations and parkinsonism‐dementia‐amyotrophic lateral sclerosis complex , 2005, Annals of neurology.

[88]  Y. Agid,et al.  G2019S LRRK2 mutation in French and North African families with Parkinson's disease , 2005, Annals of neurology.

[89]  M. Canesi,et al.  The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson’s disease and originates from a common ancestor , 2005, Journal of Medical Genetics.

[90]  P. Bauer,et al.  PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism , 2005, European Journal of Human Genetics.

[91]  H. Payami,et al.  Escaping Parkinson's disease: A neurologically healthy octogenarian with the LRRK2 G2019S mutation , 2005, Movement disorders : official journal of the Movement Disorder Society.

[92]  J. Schulz,et al.  Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. , 2005, Human molecular genetics.

[93]  M. Farrer,et al.  LRRK2 R1441G in Spanish patients with Parkinson's disease , 2005, Neuroscience Letters.

[94]  S. Chaturvedi,et al.  Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes , 2005, Neurology.

[95]  N. Hattori,et al.  Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism , 2005, Neurology.

[96]  Kazuko Hasegawa,et al.  An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family , 2005, Annals of neurology.

[97]  J. Jankovic,et al.  Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation , 2005, Annals of neurology.

[98]  Timothy Lynch,et al.  Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. , 2005, American journal of human genetics.

[99]  Nicholas W Wood,et al.  A common LRRK2 mutation in idiopathic Parkinson's disease , 2005, The Lancet.

[100]  Thomas Meitinger,et al.  Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.

[101]  Andrew Lees,et al.  Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.

[102]  K. Marder,et al.  Distribution, type, and origin of Parkin mutations: Review and case studies , 2004, Movement disorders : official journal of the Movement Disorder Society.

[103]  R. Krüger,et al.  Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7) , 2004, Human mutation.

[104]  A Dürr,et al.  Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[105]  Philippe Amouyel,et al.  α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[106]  Pietro Cortelli,et al.  Homozygous PINK1 C‐terminus mutation causing early‐onset parkinsonism , 2004, Annals of neurology.

[107]  M. Iwata,et al.  Parkin-positive autosomal recessive juvenile parkinsonism with α-synuclein-positive inclusions , 2004, Neurology.

[108]  Janel O. Johnson,et al.  SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies , 2004, Neurology.

[109]  A. Singleton,et al.  Analysis of an early‐onset Parkinson's disease cohort for DJ‐1 mutations , 2004, Movement disorders : official journal of the Movement Disorder Society.

[110]  R. P. Maguire,et al.  PET neuroimaging and mutations in the DJ-1 gene , 2004, Journal of Neural Transmission.

[111]  R. Nussbaum,et al.  Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.

[112]  I. McKeith,et al.  Dementia with Lewy bodies and Parkinson's disease. , 2004, Parkinsonism & related disorders.

[113]  J. Noth,et al.  DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease , 2004, Neurology.

[114]  J. Hoenicka,et al.  The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.

[115]  Matthew J. Farrer,et al.  Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications , 2004 .

[116]  M. Farrer,et al.  Parkin variants in North American Parkinson's disease: Cases and controls , 2003, Movement disorders : official journal of the Movement Disorder Society.

[117]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[118]  J. Jankovic,et al.  Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families. , 2003, Human molecular genetics.

[119]  N. Quinn,et al.  The role of pathogenic DJ‐1 mutations in Parkinson's disease , 2003, Annals of neurology.

[120]  Vincenzo Bonifati,et al.  Early‐onset Parkinson's disease caused by a compound heterozygous DJ‐1 mutation , 2003, Annals of neurology.

[121]  Alexandra Durr,et al.  How much phenotypic variation can be attributed to parkin genotype? , 2003, Annals of neurology.

[122]  Vincenzo Bonifati,et al.  Clinical features and neuroimaging of PARK7‐linked parkinsonism , 2003, Movement disorders : official journal of the Movement Disorder Society.

[123]  N. Hattori,et al.  Autosomal recessive parkinsonism linked to parkin gene in a Tunisian family. Clinical, genetic and pathological study. , 2003, Parkinsonism & related disorders.

[124]  J. Haines,et al.  Parkin mutations and susceptibility alleles in late‐onset Parkinson's disease , 2003, Annals of neurology.

[125]  L. Seeberger,et al.  Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease , 2003, Neurology.

[126]  Paola Piccini,et al.  Clinical and subclinical dopaminergic dysfunction in PARK6‐linked parkinsonism: An 18F‐dopa PET study , 2002, Annals of neurology.

[127]  Patrizia Rizzu,et al.  Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.

[128]  Hreinn Stefánsson,et al.  A susceptibility gene for late‐onset idiopathic Parkinson's disease , 2002, Annals of neurology.

[129]  Nicola Pavese,et al.  Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study. , 2002, Brain : a journal of neurology.

[130]  Christine Klein,et al.  Role of parkin mutations in 111 community‐based patients with early‐onset parkinsonism , 2002, Annals of neurology.

[131]  J. Trojanowski,et al.  Concurrence of α-synuclein and tau brain pathology in the Contursi kindred , 2002, Acta Neuropathologica.

[132]  Karl Herholz,et al.  The striatal dopaminergic deficit is dependent on the number of mutant alleles in a family with mutations in the parkin gene: evidence for enzymatic parkin function in humans , 2002, Neuroscience Letters.

[133]  X. Breakefield,et al.  Phenotypic variability in a large kindred (Family LA) with deletions in the parkin gene , 2002, Movement disorders : official journal of the Movement Disorder Society.

[134]  S. Tsuji,et al.  A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2–q13.1 , 2002, Annals of neurology.

[135]  C. V. van Duijn,et al.  Localization of autosomal recessive early‐onset parkinsonism to chromosome 1p36 (PARK7) in an independent dataset , 2002, Annals of neurology.

[136]  D. Hernandez,et al.  Lewy bodies and parkinsonism in families with parkin mutations , 2001, Annals of neurology.

[137]  Glenda M. Halliday,et al.  Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr α‐synuclein mutation , 2001 .

[138]  N. Quinn,et al.  Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations , 2001, Neurology.

[139]  Hitoshi Takahashi,et al.  An autopsy case of autosomal‐recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene , 2000, Movement disorders : official journal of the Movement Disorder Society.

[140]  J. Haines,et al.  The α-synuclein gene is not a major risk factor in familial Parkinson disease , 1999, Neurogenetics.

[141]  M. Polymeropoulos,et al.  Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein. , 1999, American journal of human genetics.

[142]  Y. Agid,et al.  A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. , 1999, Human molecular genetics.

[143]  G. Hadjigeorgiou,et al.  Mutated α-synuclein gene in two Greek kindreds with familial PD: Incomplete penetrance? , 1999, Neurology.

[144]  Georg Auburger,et al.  The ubiquitin pathway in Parkinson's disease , 1998, Nature.

[145]  T. Kondo,et al.  Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q , 1998, Neurology.

[146]  H Okazaki,et al.  Hereditary form of parkinsonism—dementia , 1998, Annals of neurology.

[147]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[148]  B. Müller-Myhsok,et al.  A susceptibility locus for Parkinson's disease maps to chromosome 2p13 , 1998, Nature Genetics.

[149]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[150]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[151]  A A Schäffer,et al.  Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27. , 1997, American journal of human genetics.

[152]  S. Tsuji,et al.  Familial juvenile parkinsonism , 1994, Neurology.

[153]  Douglas C. Miller,et al.  A large kindred with autosomal dominant Parkinson's disease , 1990, Annals of neurology.

[154]  A. Destée,et al.  Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms. , 2009, Archives of neurology.

[155]  A. Bonnet,et al.  A-SYNUCLEIN GENE DUPLICATION IS PRESENT IN SPORADIC PARKINSON DISEASE. Authors' reply , 2008 .

[156]  T. Yen,et al.  PINK1 mutation in Taiwanese early-onset parkinsonism : clinical, genetic, and dopamine transporter studies. , 2007, Journal of neurology.

[157]  C. Ki,et al.  The Ala53Thr mutation in the alpha-synuclein gene in a Korean family with Parkinson disease. , 2007, Clinical genetics.

[158]  Thomas S. Jacques,et al.  Lewy body Parkinson , 2005 .

[159]  A Dürr,et al.  Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. , 2004, Lancet.

[160]  Nir Giladi,et al.  Parkin mutation associated parkinsonism and cognitive decline, comparison to early onset Parkinson’s disease , 2004, Journal of Neural Transmission.

[161]  M. Farrer,et al.  Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. , 2004, Annals of neurology.

[162]  Philippe Amouyel,et al.  Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. , 2004, Lancet.

[163]  J. Trojanowski,et al.  Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred. , 2002, Acta neuropathologica.

[164]  G. Halliday,et al.  Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation. , 2001, Annals of neurology.

[165]  G. Hadjigeorgiou,et al.  Mutated alpha-synuclein gene in two Greek kindreds with familial PD: incomplete penetrance? , 1999, Neurology.

[166]  S. Gilman,et al.  Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.

[167]  J. Haines,et al.  The alpha-synuclein gene is not a major risk factor in familial Parkinson disease. , 1999, Neurogenetics.

[168]  R. Krüger,et al.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.

[169]  S E Ide,et al.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.

[170]  M G Spillantini,et al.  Alpha-synuclein in Lewy bodies. , 1997, Nature.

[171]  M. DomínguezCarmona,et al.  [Epidemiology of Parkinson disease]. , 1989, Anales de la Real Academia Nacional de Medicina.

[172]  J. Y. Kim,et al.  Does hereditary hemochromatosis influence the age of onset of Huntington's disease? , 2010, Movement disorders : official journal of the Movement Disorder Society.